PRADX
Basic information
Region (hg38): 11:1760348-1762486
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Neuronal ceroid lipofuscinosis (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRADX gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 40 | 44 | 93 | |||
Total | 3 | 3 | 40 | 44 | 3 |
Highest pathogenic variant AF is 0.00000657
Variants in PRADX
This is a list of pathogenic ClinVar variants found in the PRADX region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-1761176-G-C | Benign (Jun 26, 2018) | |||
11-1761290-G-T | Neuronal ceroid lipofuscinosis | Likely benign (Sep 07, 2022) | ||
11-1761291-C-A | not specified • Neuronal ceroid lipofuscinosis | Benign/Likely benign (Jan 29, 2024) | ||
11-1761292-T-C | Neuronal ceroid lipofuscinosis | Likely benign (Jun 01, 2022) | ||
11-1761295-G-T | Neuronal ceroid lipofuscinosis | Likely benign (Aug 03, 2023) | ||
11-1761301-A-G | Neuronal ceroid lipofuscinosis | Likely benign (Dec 22, 2023) | ||
11-1761302-T-A | Neuronal ceroid lipofuscinosis | Likely benign (May 12, 2022) | ||
11-1761308-C-A | Neuronal ceroid lipofuscinosis | Likely pathogenic (Sep 02, 2022) | ||
11-1761308-C-T | Neuronal ceroid lipofuscinosis | Likely pathogenic (Mar 08, 2023) | ||
11-1761309-G-A | not specified • Neuronal ceroid lipofuscinosis | Conflicting classifications of pathogenicity (Feb 23, 2024) | ||
11-1761314-T-C | Neuronal ceroid lipofuscinosis | Uncertain significance (Dec 11, 2021) | ||
11-1761321-C-T | not specified • Neuronal ceroid lipofuscinosis • Inborn genetic diseases | Benign/Likely benign (Jan 11, 2025) | ||
11-1761322-T-C | Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 16, 2022) | ||
11-1761326-G-A | Neuronal ceroid lipofuscinosis | Uncertain significance (Nov 01, 2022) | ||
11-1761330-C-T | Neuronal ceroid lipofuscinosis | Likely benign (Apr 12, 2023) | ||
11-1761332-C-T | not specified | Uncertain significance (Sep 06, 2024) | ||
11-1761333-G-A | Neuronal ceroid lipofuscinosis • CTSD-related disorder | Likely benign (Dec 13, 2023) | ||
11-1761333-G-C | Neuronal ceroid lipofuscinosis | Likely benign (Mar 23, 2023) | ||
11-1761334-G-A | Neuronal ceroid lipofuscinosis | Uncertain significance (Dec 22, 2019) | ||
11-1761338-T-G | Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 24, 2021) | ||
11-1761342-C-A | Neuronal ceroid lipofuscinosis | Likely benign (Aug 17, 2023) | ||
11-1761345-C-T | Neuronal ceroid lipofuscinosis | Likely benign (Jun 16, 2023) | ||
11-1761347-C-A | Neuronal ceroid lipofuscinosis | Pathogenic (Dec 09, 2023) | ||
11-1761347-C-G | Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 27, 2021) | ||
11-1761347-C-T | Neuronal ceroid lipofuscinosis | Uncertain significance (Jun 24, 2022) |
GnomAD
Source:
dbNSFP
Source: